Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.

ABSTRACT:

Objective

To report initial results of a planned multicenter year-long prospective study examining the risk and impact of COVID-19 among persons with neuroinflammatory disorders (NID), particularly multiple sclerosis (MS).

Methods

In April 2020, we deployed online questionnaires to individuals in their home environment to assess the prevalence and potential risk factors of suspected COVID-19 in persons with NID (PwNID) and change in their neurological care.

Results

Our cohort included 1115 participants (630 NID, 98% MS; 485 reference) as of 30 April 2020. 202 (18%) participants, residing in areas with high COVID-19 case prevalence, met the April 2020 CDC symptom criteria for suspected COVID-19, but only 4% of all participants received testing given testing shortages.

SUBMITTER: Levin SN 

PROVIDER: S-EPMC8013889 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature